Quality at Scale: The Rise of Branded Generics in Reimagining 2026 Biopharma Business Models
"Global Demand Outlook for Executive Summary Branded Generics Market Size and Share During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 5.5%, primarily driven by increasing healthcare expenditure, rising prevalence of chronic diseases, and the demand for affordable, high-quality medication in both developed and emerging markets Global Branded...
0 Commentarios 0 Acciones